VOR BIOPHARMA INC. (VOR)
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Altai Announces Voting Results From Shareholder Meeting
Unique, Boutique and Unmistakably Lisa Vanderpump: The Vanderpump Hotel Now Accepting Reservations for May Arrivals
Emera Incorporated announces the closing of the offering of US$750 million Aggregate Principal Amount of Fixed-to-Fixed Reset Rate Junior Subordinated Notes
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
Janus Living Closes on a New $600 Million Credit Facility to Enhance Liquidity and Support External Growth
Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility
MPLX LP to Report First-Quarter Results on May 5, 2026
KKR Announces Intra-Quarter Monetization Activity Update for the First Quarter
South Plains Financial, Inc. and BOH Holdings, Inc. Announce All Required Regulatory and Shareholder Approvals Received for Proposed Merger